Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Charles River Laboratories Intl (CRL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,310,718
  • Shares Outstanding, K 48,754
  • Annual Sales, $ 2,266 M
  • Annual Income, $ 226,370 K
  • 60-Month Beta 0.99
  • Price/Sales 2.80
  • Price/Cash Flow 13.72
  • Price/Book 4.53

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate 1.56
  • Number of Estimates 10
  • High Estimate 1.61
  • Low Estimate 1.52
  • Prior Year 1.62
  • Growth Rate Est. (year over year) -3.70%

Price Performance

See More
Period Period Low Period High Performance
1-Month
126.63 +1.43%
on 05/23/19
144.26 -10.97%
on 04/29/19
-7.60 (-5.59%)
since 04/23/19
3-Month
126.63 +1.43%
on 05/23/19
149.07 -13.84%
on 04/03/19
-16.23 (-11.22%)
since 02/22/19
52-Week
103.00 +24.70%
on 01/03/19
149.07 -13.84%
on 04/03/19
+21.95 (+20.61%)
since 05/23/18

Most Recent Stories

More News
20th Century New York Mansion Joins The Ascend Hotel Collection

The Ascend Hotel Collection by Choice Hotels International, Inc. (NYSE: CHH), a portfolio of unique, boutique, and historic hotels and resorts that reflect their surrounding community, now has a century-old...

CHH : 83.21 (-1.36%)
CRL : 128.44 (-0.77%)
Charles River Laboratories Invests in Resero Analytics(TM)

Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has invested in Resero Analytics(TM), a software company focused on providing solutions to the biopharmaceutical...

CRL : 128.44 (-0.77%)
Top 5 Companies in the Life Sciences Tools & Services Industry with the Best Relative Performance (FLDM , CRL , WAT , ILMN , PKI )

Here are the top 5 stocks in the Life Sciences Tools & Services industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were...

WAT : 205.05 (-1.06%)
CRL : 128.44 (-0.77%)
FLDM : 12.18 (+1.50%)
Charles River Laboratories (CRL) Beats Q1 Earnings and Revenue Estimates

Charles River (CRL) delivered earnings and revenue surprises of 1.45% and 0.70%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

CRL : 128.44 (-0.77%)
Charles River: 1Q Earnings Snapshot

WILMINGTON, Mass. (AP) _ Charles River Laboratories International Inc. (CRL) on Tuesday reported first-quarter profit of $55.1 million.

CRL : 128.44 (-0.77%)
Charles River Laboratories Announces First-Quarter 2019 Results

--- First-Quarter GAAP Earnings per Share of $1.11 and Non-GAAP Earnings per Share of $1.40 -

CRL : 128.44 (-0.77%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charles River Laboratories International, Inc. - CRL

Pomerantz LLP is investigating claims on behalf of investors of Charles River Laboratories International, Inc. ("Charles River" or the "Company") (NYSE: CRL). Such investors are advised to contact Robert...

CRL : 128.44 (-0.77%)
Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. (CRL) on Behalf of Stockholders and Encourages CRL Investors to Contact the Firm

Bragar Eagel & Squire, P.C. is investigating potential claims against Charles River Laboratories International, Inc. (NYSE: CRL). Our investigation concerns whether Charles River has violated the federal...

CRL : 128.44 (-0.77%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charles River Laboratories International, Inc. - CRL

Pomerantz LLP is investigating claims on behalf of investors of Charles River Laboratories International, Inc. ("Charles River" or the "Company") . Such investors are advised to contact Robert S. Willoughby...

CRL : 128.44 (-0.77%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charles River Laboratories International, Inc. - CRL

Pomerantz LLP is investigating claims on behalf of investors of Charles River Laboratories International, Inc. ("Charles River" or the "Company") (NYSE: CRL). Such investors are advised to contact Robert...

CRL : 128.44 (-0.77%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators mostly agree with the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade CRL with:

Business Summary

Charles River Laboratories International, Inc. provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Their dedicated employees are focused...

See More

Key Turning Points

2nd Resistance Point 129.75
1st Resistance Point 129.10
Last Price 128.44
1st Support Level 127.21
2nd Support Level 125.97

See More

52-Week High 149.07
Fibonacci 61.8% 131.47
Last Price 128.44
Fibonacci 50% 126.03
Fibonacci 38.2% 120.60
52-Week Low 103.00

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar